Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium camphorsulfonate is the sodium salt of camphorsulfonic acid, a derivative of camphor. Historically, it was utilized in clinical medicine as an analeptic agent, serving as a respiratory and circulatory stimulant to treat conditions such as respiratory failure or cardiovascular collapse. While its clinical use in humans has largely been superseded by more targeted therapies, it remains a subject of research for its properties as a chiral resolving agent and, more recently, as a biomimetic electrolyte additive in zinc-iodine batteries to suppress dendrite formation and side reactions. It is also occasionally used in veterinary medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium camphorsulfonate.